Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Neuroenhancement through cognitive training and anodal tDCS in multiple sclerosis.
The Many Facets of Cell Injury: Angiogenesis to Autophagy.
Confounding in association studies: month of birth and multiple sclerosis.
LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.
Ultrasound aspects in therapy-naive CIDP compared to long-term treated CIDP.
Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosis.
The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment.
Transcriptional response to interferon beta-1a treatment in patients with secondary progressive multiple sclerosis.
Acorda Therapeutics announces top line results of post-marketing commitment study exploring 5 mg dose of dalfampridine-ER
Artielle Immunotherapeutics Announces Positive Results of Phase ! Multiple Sclerosis Trial
Genmab announces details of planned ofatumumab Phase II study in multiple sclerosis
Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects.
Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma
Assessment of the effect of interferon-beta1a therapy on thyroid and salivary gland functions in patients with multiple sclerosis using quantitative salivary gland scintigraphyz.
Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria.
Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
Leber's hereditary optic neuropathy associated with multiple sclerosis: Harding's syndrome.
Severe anemia in a patient with multiple sclerosis treated with natalizumab.
CHMP assessment report for Sovrima (International nonproprietary name: idebenone)
A genome screen for multiple sclerosis in Italian families.
The epidemiology of multiple sclerosis in Latin America and the Caribbean: a systematic review.
Rehabilitation interventions in multiple sclerosis: an overview.
A comparative study of experimental mouse models of central nervous system demyelination.
Assessment of sphingosine-1-phosphate receptor expression and associated intracellular signaling cascades in primary cells of the human central nervous system.
Efficacy and safety of interferon beta-1b sc in older RRMS patients--a posthoc analysis of the BEYOND study.
Pages
« first
‹ previous
…
98
99
100
101
102
103
104
105
106
…
next ›
last »